120 related articles for article (PubMed ID: 8756739)
1. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
[TBL] [Abstract][Full Text] [Related]
2. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
[TBL] [Abstract][Full Text] [Related]
3. [Antithrombin III and alpha 2-antiplasmin in blood of patients operated on for benign prostatic hyperplasia].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):75-6. PubMed ID: 8756735
[TBL] [Abstract][Full Text] [Related]
4. [Activity of alpha 1-antitrypsin in blood of patients operated on for tumor and benign hyperplasia of the prostate].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):77-8. PubMed ID: 8756736
[TBL] [Abstract][Full Text] [Related]
5. [The activity of alpha-2 macroglobulin in the blood of patients with prostatic carcinoma].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F; Zastawna E
Pol Merkur Lekarski; 1997 Jan; 2(9):196-8. PubMed ID: 10907027
[TBL] [Abstract][Full Text] [Related]
6. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
7. [Changes of fibrinolysis during labour with and without aprotinin application].
Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
[TBL] [Abstract][Full Text] [Related]
8. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.
Kamper EF; Kopeikina LT; Koutsoukos V; Stavridis J
J Rheumatol; 1997 Feb; 24(2):262-8. PubMed ID: 9034981
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.
Fair DS; Plow EF
J Lab Clin Med; 1983 Mar; 101(3):372-84. PubMed ID: 6186756
[TBL] [Abstract][Full Text] [Related]
10. [Effect of venous stasis on plasminogen activation and plasma alpha 2-antiplasmin levels in type II diabetes mellitus].
Longoni P; Montani N; Gangale MG; Gamba G
Recenti Prog Med; 1987; 78(7-8):323-7. PubMed ID: 3423401
[No Abstract] [Full Text] [Related]
11. [Tissue plasminogen activator in urine of patients with prostatic carcinoma and benign prostatic hyperplasia].
Zietek Z; Iwan-Zietek I; Kotschy M; Wolski Z; Kulwas A; Białkowska A
Pol Merkur Lekarski; 1997 Apr; 2(10):266-7. PubMed ID: 9377662
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2-antiplasmin: functional characterization and metabolism in a heterozygote deficient patient.
Knot EA; ten Cate JW; Lamping RJ; Gie LK
Thromb Haemost; 1986 Jun; 55(3):375-8. PubMed ID: 3750266
[TBL] [Abstract][Full Text] [Related]
13. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.
Collen D
Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468
[No Abstract] [Full Text] [Related]
14. [Plasmin-alpha 2-antiplasmin complexes in blood of patient with lichen planus against the background of other fibrinolysis parameters].
Wankiewicz A; Iwan-Zietek I; Kotschy M; Zwolska A
Pol Merkur Lekarski; 2003 Jul; 15(85):72-4. PubMed ID: 14593965
[TBL] [Abstract][Full Text] [Related]
15. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
16. [Activity of protein C in blood of patients with prostatic carcinoma].
Iwan-Zietek I; Zietek Z; Kotschy M; Tyloch F; Zastawna E
Pol Tyg Lek; 1996 Feb; 51(6-9):94-5. PubMed ID: 8756742
[TBL] [Abstract][Full Text] [Related]
17. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
Janody D; Droulle C; Adjizian JC; Ostermann G; Poynard JP; Jeunehomme G; Leutenegger M; Potron G
J Mal Vasc; 1982; 7(3):221-4. PubMed ID: 6815291
[TBL] [Abstract][Full Text] [Related]
18. Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency.
Leebeek FW; Stibbe J; Knot EA; Kluft C; Gomes MJ; Beudeker M
Thromb Haemost; 1988 Feb; 59(1):96-100. PubMed ID: 3363537
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of PAI-1 and alpha 2-antiplasmin contribute to enhanced fibrinolytic activity in divers.
Radziwon P; Olszański R; Tomaszewski R; Lipska A; Dabrowiecki Z; Korzeniewski K; Siermontowski P; Boczkowska-Radziwon B
Thromb Res; 2007; 121(2):235-40. PubMed ID: 17521709
[TBL] [Abstract][Full Text] [Related]
20. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
